Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19431248rdf:typepubmed:Citationlld:pubmed
pubmed-article:19431248lifeskim:mentionsumls-concept:C0014544lld:lifeskim
pubmed-article:19431248lifeskim:mentionsumls-concept:C0543467lld:lifeskim
pubmed-article:19431248lifeskim:mentionsumls-concept:C0442043lld:lifeskim
pubmed-article:19431248lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:19431248lifeskim:mentionsumls-concept:C1521761lld:lifeskim
pubmed-article:19431248lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:19431248pubmed:dateCreated2009-5-11lld:pubmed
pubmed-article:19431248pubmed:abstractTextAn objective of the study is an analysis of the results of surgical treatment and influence of resection volume on the treatment outcome. Sixty-four patients, aged 7-46 years, with an epileptic focus in a temporal lobe have been studied. Patients have been stratified into 2 groups. The first group included 55 patients with epileptogenic lesions of a temporal lobe (monoregional lesions) and the second one--9 patients who, along with the lesion of one temporal lobe, had the signs of lesions in other brain areas (multiregional lesions). In the group of patients with monoregional lesions, a resection of the affected area has been performed. In other patients, the techniques of resection of frontal-medial temporal lobe regions within the scope of the area of steady epileptiform activity have been used. The results have been assessed with the modified Engel scale: class I--an absence of clinically manifested seizures (auras are possible); class II--seizures that do not impact quality of life; class III--a decrease of seizures frequency by more than 80%; class IV--an absence of substantial improvement. In the monoregional lesions, the satisfactory results (I-II classes) were observed in 39 patients (74%), including outcomes of class I (28 patients). In other 16 cases outcomes of classes III and IV were observed. In the multiregional lesions and cryptogenic (possibly symptomatic) partial epilepsy, outcomes of classes III and IV were observed in all patients, regardless of the resection volume. In conclusion, the highest efficacy with regard to frequency and severity of seizures is achieved by resections including the whole area of visualized lesion and border-line area of steady epileptic activity, the identification of which demands the intrasurgery neurophysiologic study. In the extensive and multiregional lesions, the resection surgery confined to one temporal lobe has low effect.lld:pubmed
pubmed-article:19431248pubmed:languageruslld:pubmed
pubmed-article:19431248pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19431248pubmed:citationSubsetIMlld:pubmed
pubmed-article:19431248pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19431248pubmed:statusMEDLINElld:pubmed
pubmed-article:19431248pubmed:issn1997-7298lld:pubmed
pubmed-article:19431248pubmed:authorpubmed-author:KonovalovA...lld:pubmed
pubmed-article:19431248pubmed:authorpubmed-author:ArkhipovaN...lld:pubmed
pubmed-article:19431248pubmed:authorpubmed-author:GusevE IEIlld:pubmed
pubmed-article:19431248pubmed:authorpubmed-author:GekhtA BABlld:pubmed
pubmed-article:19431248pubmed:authorpubmed-author:LubninA IuAIulld:pubmed
pubmed-article:19431248pubmed:authorpubmed-author:BuklinaS BSBlld:pubmed
pubmed-article:19431248pubmed:authorpubmed-author:LebedevaA VAVlld:pubmed
pubmed-article:19431248pubmed:authorpubmed-author:ProninI NINlld:pubmed
pubmed-article:19431248pubmed:authorpubmed-author:ShishkinaL...lld:pubmed
pubmed-article:19431248pubmed:authorpubmed-author:StepanenkoA...lld:pubmed
pubmed-article:19431248pubmed:authorpubmed-author:AriasovaI KIKlld:pubmed
pubmed-article:19431248pubmed:issnTypePrintlld:pubmed
pubmed-article:19431248pubmed:volumeSuppl 2lld:pubmed
pubmed-article:19431248pubmed:ownerNLMlld:pubmed
pubmed-article:19431248pubmed:authorsCompleteYlld:pubmed
pubmed-article:19431248pubmed:pagination3-9lld:pubmed
pubmed-article:19431248pubmed:meshHeadingpubmed-meshheading:19431248...lld:pubmed
pubmed-article:19431248pubmed:meshHeadingpubmed-meshheading:19431248...lld:pubmed
pubmed-article:19431248pubmed:meshHeadingpubmed-meshheading:19431248...lld:pubmed
pubmed-article:19431248pubmed:meshHeadingpubmed-meshheading:19431248...lld:pubmed
pubmed-article:19431248pubmed:meshHeadingpubmed-meshheading:19431248...lld:pubmed
pubmed-article:19431248pubmed:meshHeadingpubmed-meshheading:19431248...lld:pubmed
pubmed-article:19431248pubmed:meshHeadingpubmed-meshheading:19431248...lld:pubmed
pubmed-article:19431248pubmed:meshHeadingpubmed-meshheading:19431248...lld:pubmed
pubmed-article:19431248pubmed:meshHeadingpubmed-meshheading:19431248...lld:pubmed
pubmed-article:19431248pubmed:meshHeadingpubmed-meshheading:19431248...lld:pubmed
pubmed-article:19431248pubmed:meshHeadingpubmed-meshheading:19431248...lld:pubmed
pubmed-article:19431248pubmed:meshHeadingpubmed-meshheading:19431248...lld:pubmed
pubmed-article:19431248pubmed:meshHeadingpubmed-meshheading:19431248...lld:pubmed
pubmed-article:19431248pubmed:meshHeadingpubmed-meshheading:19431248...lld:pubmed
pubmed-article:19431248pubmed:meshHeadingpubmed-meshheading:19431248...lld:pubmed
pubmed-article:19431248pubmed:meshHeadingpubmed-meshheading:19431248...lld:pubmed
pubmed-article:19431248pubmed:year2008lld:pubmed
pubmed-article:19431248pubmed:articleTitle[Pharmacoresistant temporal epilepsy: surgical treatment and analysis of factors influencing on its results].lld:pubmed
pubmed-article:19431248pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19431248pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:19431248pubmed:publicationTypeEnglish Abstractlld:pubmed